HomeNewsMika Well being companions with pharma giants for girls's oncology initiative

Mika Well being companions with pharma giants for girls's oncology initiative

Oncology-focused digital therapeutics firm Mika Well being introduced a partnership with pharma corporations AstraZeneca and Daiichi Sankyo for an initiative dubbed “UNITE” to supply digital therapeutics to girls present process breast most cancers therapies. 

Mika Well being’s app provides most cancers sufferers entry to psychological help to scale back disease-related nervousness, despair and stress. Sufferers can monitor unintended effects from drugs, obtain treatment reminders, acquire training and vitamin recommendation, and coordinate appointments. 

The digital therapeutic, already licensed as a medical system and launched within the EU, could be personalised to a person’s particular kind of most cancers.

By the partnership, Mika Well being’s choices shall be used alongside pharmaceutical remedy.

First, German-speaking sufferers in Switzerland can entry the providing, after which the businesses will broaden to incorporate Switzerland’s French- and Italian-speaking areas. 

“Digital therapies have gotten more and more essential in trendy most cancers therapy,” Adam Nosal, head of oncology at AstraZeneca Switzerland, stated in a press release. “This partnership with Mika permits us to broaden entry to holistic most cancers care and achieve insights that may form our broader efforts to enhance therapeutic choices for most cancers sufferers.”

THE LARGER TREND

In June, Mika Well being and the worldwide nonprofit Most cancers Assist Group introduced they’ll present an AI-enabled oncology-focused digital therapeutic for U.S.-based most cancers sufferers and their caregivers to entry psychological well being and different help companies freed from cost. 

See also  Q&A: Google on creating the lack of pulse detection know-how

Earlier this yr, the corporate introduced a partnership with AI oncology agency Large Bio to supply free entry to Miko’s choices by Large Bio’s platform.

Mika sufferers would even be given the power to take part in Large’s AI-enabled biomarker testing and medical trial matching choices. 

 

The HIMSS AI in Healthcare Discussion board is scheduled to happen September 5-6 in Boston. Be taught extra and register.

 

Source link

RELATED ARTICLES

Most Popular